- Home
- CISS vs BDRX Comparison
CISS vs BDRX Comparison
Compare CISS & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | BDRX |
|---|---|---|
| Founded | 2022 | 2000 |
| Country | Greece | United Kingdom |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 1.6M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CISS | BDRX |
|---|---|---|
| Price | $1.60 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 243.7K |
| Earning Date | 05-19-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.60 |
| 52 Week High | $6.06 | $11.88 |
Technical Indicators
Market Signals| Indicator | CISS | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 19.48 |
| Support Level | $0.34 | $0.60 |
| Resistance Level | $2.39 | $1.50 |
| Average True Range (ATR) | 0.38 | 0.14 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 27.33 | 4.41 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including national and private industrial users, commodity producers, and traders. The company owns and operates a fleet of two dry bulk carriers that transport bulk commodities such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.